Schedule 13G ownership disclosure
NeuroBo Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 64132R206
Event date: 2022-11-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 312,430
- Percent of class
- 7.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-22-011512
- Form type
- SC 13G
- Filer
- Altium Capital Management LLC
- CIK
- CIK 1746382
- Filed
- Nov 17, 2022
- Reporting period
- Nov 04, 2022
- Description
- Schedule 13G beneficial ownership